RenovoRx, Inc. (RNXT)

1.58 +0.03 (+1.94%) USD  |  NASDAQ  |  Oct 02, 16:00
1.59 +0.01 (+0.63%) After-Hours: 20:00
More

RenovoRx EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for RNXT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to . Start Trial.
Date Value

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Enanta Pharmaceuticals, Inc. --
Travere Therapeutics, Inc. --
REGENXBIO, Inc. --
Krystal Biotech, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade